Warning letter
Abbey Color, Inc.: warning letter of Feb 19, 2013
FDA warning letter 307138 · Philadelphia District Office
Key facts
| Reference number | 307138 |
|---|---|
| Company | Abbey Color, Inc. |
| Subject | CGMP/Active Pharmaceutical Ingredient (API)/Adulterated |
| Issue date | Feb 19, 2013 |
| Posted date | Feb 19, 2013 |
| Issuing office | Philadelphia District Office |
| Product type | Drugs |
| Inspection city | Philadelphia |
| Inspection ZIP | 19134 |
| Inspection start date | Mar 13, 2012 |
| Letter on fda.gov | web.archive.org |
At a glance
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: